ICON executives say technology is a key factor in the $12 billion acquisition. PRA Health Sciences has a mobile health platform that enables patients to participate in clinical trials from their homes.
ICON executives say technology is a key factor in the $12 billion acquisition. PRA Health Sciences has a mobile health platform that enables patients to participate in clinical trials from their homes.
Copyright © 2024 | WordPress Theme by MH Themes
